Motilal Oswal Alternates has invested $72 million in Hyderabad-based medical devices company Sensa Core, marking a strong vote of confidence in India’s growing diagnostics and medtech manufacturing ecosystem.

Founded in 2006 by Ravi Kumar Meruva, Sensa Core will use the fresh funding to speed up product development, expand manufacturing, and grow its global presence, especially in the in-vitro diagnostics (IVD) segment.

India currently imports more than 75% of its medical devices, with annual imports crossing $8.5 billion. Motilal Oswal Alternates said the investment supports the need to build high-quality, affordable medical devices in India for both domestic use and global markets.

Sensa Core designs, manufactures, and distributes diagnostic devices, and is a market leader in electrolyte analysers, with its products used in over 40,000 hospitals and diagnostic labs across India. The company also exports to 78+ countries and has expanded into glucometers, haemoglobin meters, and arterial blood gas analysers.

The company currently operates a manufacturing unit in Pashamylaram, Hyderabad, and plans to commission a new facility at the Medical Device Park in Sultanpur to increase capacity and support new product launches.

Meruva said the investment will help the company focus on automation, innovation in point-of-care diagnostics, and improving healthcare access through local manufacturing at scale.

Veda Corporate Advisors advised Sensa Core on the transaction.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!